IT1278052B1 - Uso delle immunoglobuline della classe g, in particolare delle immunoglobuline per uso endovenoso o per uso intramuscolare, per - Google Patents

Uso delle immunoglobuline della classe g, in particolare delle immunoglobuline per uso endovenoso o per uso intramuscolare, per

Info

Publication number
IT1278052B1
IT1278052B1 IT95RM000154A ITRM950154A IT1278052B1 IT 1278052 B1 IT1278052 B1 IT 1278052B1 IT 95RM000154 A IT95RM000154 A IT 95RM000154A IT RM950154 A ITRM950154 A IT RM950154A IT 1278052 B1 IT1278052 B1 IT 1278052B1
Authority
IT
Italy
Prior art keywords
immunoglobulins
dermatitis
class
intramuscular
intravenous
Prior art date
Application number
IT95RM000154A
Other languages
English (en)
Inventor
Simone Claudio De
Pietro Bruschi
Original Assignee
Mendes Srl
Prex Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11403139&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1278052(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mendes Srl, Prex Srl filed Critical Mendes Srl
Priority to IT95RM000154A priority Critical patent/IT1278052B1/it
Publication of ITRM950154A0 publication Critical patent/ITRM950154A0/it
Priority to CA2213500A priority patent/CA2213500C/en
Priority to PT96905988T priority patent/PT814837E/pt
Priority to US08/913,339 priority patent/US6410019B1/en
Priority to KR1019970705915A priority patent/KR19980702515A/ko
Priority to DE69625182T priority patent/DE69625182T3/de
Priority to ES96905988T priority patent/ES2187635T5/es
Priority to AT96905988T priority patent/ATE228854T1/de
Priority to EP96905988A priority patent/EP0814837B2/en
Priority to JP52743196A priority patent/JP3939346B2/ja
Priority to PCT/IT1996/000047 priority patent/WO1996028186A1/en
Priority to DK96905988T priority patent/DK0814837T4/da
Publication of ITRM950154A1 publication Critical patent/ITRM950154A1/it
Publication of IT1278052B1 publication Critical patent/IT1278052B1/it
Application granted granted Critical
Priority to US10/147,855 priority patent/US7217416B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/809—Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT95RM000154A 1995-03-14 1995-03-14 Uso delle immunoglobuline della classe g, in particolare delle immunoglobuline per uso endovenoso o per uso intramuscolare, per IT1278052B1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT95RM000154A IT1278052B1 (it) 1995-03-14 1995-03-14 Uso delle immunoglobuline della classe g, in particolare delle immunoglobuline per uso endovenoso o per uso intramuscolare, per
DK96905988T DK0814837T4 (da) 1995-03-14 1996-03-12 Anvendelse af G-klasse-immunoglobuliner til topikal behandling af atopisk dermatitis
DE69625182T DE69625182T3 (de) 1995-03-14 1996-03-12 Immunoglobuline der g-klasse zur lokalen behandlung von hautentzündungen
EP96905988A EP0814837B2 (en) 1995-03-14 1996-03-12 Use of g class immunoglobulins for the topical treatment of atopic dermatitis
US08/913,339 US6410019B1 (en) 1995-03-14 1996-03-12 Use of G class immunoglobulins for the topical treatment of atopic dermatitis
KR1019970705915A KR19980702515A (ko) 1995-03-14 1996-03-12 아토피성 피부염의 국소적 치료를 위한 ｇ 클래스 면역글로불린의 사용
CA2213500A CA2213500C (en) 1995-03-14 1996-03-12 Use of g class immunoglobulins for the topical treatment of atopic dermatitis
ES96905988T ES2187635T5 (es) 1995-03-14 1996-03-12 Uso de inmunoglobulinas de clase g para el tratamiento topico de dermatitis atopica.
AT96905988T ATE228854T1 (de) 1995-03-14 1996-03-12 Immunoglobuline der g-klasse zur lokalen behandlung von hautentzündungen
PT96905988T PT814837E (pt) 1995-03-14 1996-03-12 Utilizacao de imunoglobulinas da classe g para o tratamento topico da dermatite atopica
JP52743196A JP3939346B2 (ja) 1995-03-14 1996-03-12 皮膚炎の局部治療のためのｇクラス免疫グロブリンの用法
PCT/IT1996/000047 WO1996028186A1 (en) 1995-03-14 1996-03-12 Use of g class immunoglobulins for the topical treatment of atopic dermatitis
US10/147,855 US7217416B2 (en) 1995-03-14 2002-05-20 Use of gamma globulin for the topical treatment of lesions of dermatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95RM000154A IT1278052B1 (it) 1995-03-14 1995-03-14 Uso delle immunoglobuline della classe g, in particolare delle immunoglobuline per uso endovenoso o per uso intramuscolare, per

Publications (3)

Publication Number Publication Date
ITRM950154A0 ITRM950154A0 (it) 1995-03-14
ITRM950154A1 ITRM950154A1 (it) 1996-09-14
IT1278052B1 true IT1278052B1 (it) 1997-11-17

Family

ID=11403139

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95RM000154A IT1278052B1 (it) 1995-03-14 1995-03-14 Uso delle immunoglobuline della classe g, in particolare delle immunoglobuline per uso endovenoso o per uso intramuscolare, per

Country Status (12)

Country Link
US (2) US6410019B1 (it)
EP (1) EP0814837B2 (it)
JP (1) JP3939346B2 (it)
KR (1) KR19980702515A (it)
AT (1) ATE228854T1 (it)
CA (1) CA2213500C (it)
DE (1) DE69625182T3 (it)
DK (1) DK0814837T4 (it)
ES (1) ES2187635T5 (it)
IT (1) IT1278052B1 (it)
PT (1) PT814837E (it)
WO (1) WO1996028186A1 (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030059428A1 (en) * 1993-02-26 2003-03-27 Boris Skurkovich Treatment of autoimmune diseases
AU2002346008A1 (en) * 2001-06-28 2003-03-03 Dermtech International Method for detection of melanoma
US7183057B2 (en) * 2004-03-31 2007-02-27 Dermtech International Tape stripping methods for analysis of skin disease and pathological skin state
EP2152911A4 (en) * 2007-05-04 2010-05-19 Dermtech Int DIAGNOSIS OF MELANOMA BY NUCLEIC ACID ANALYSIS
CN102089444A (zh) 2008-05-14 2011-06-08 德玛泰克国际公司 利用核酸分析方法来诊断黑素瘤和太阳能雀斑
WO2010025341A2 (en) * 2008-08-28 2010-03-04 Dermtech International Determining age ranges of skin samples
CN103002907A (zh) * 2010-04-23 2013-03-27 普若拜特有限公司 湿疹治疗
EP3752645A4 (en) 2018-02-14 2022-04-13 Dermtech, Inc. NEW GENE CLASSIFIERS AND THEIR USES IN NON-MELANOMA SKIN CANCERS
WO2020198229A1 (en) 2019-03-26 2020-10-01 Dermtech, Inc. Novel gene classifiers and uses thereof in skin cancers
US20240182552A1 (en) * 2021-04-07 2024-06-06 Ajou University Industry-Academic Cooperation Foundation Pharmaceutical composition for preventing or treating immune dysregulation-related diseases comprising oxidized immunoglobulin as active ingredient

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2610854A1 (de) * 1976-03-15 1977-09-22 Biotest Serum Institut Gmbh Galenische immunglobulinzubereitung
EP0127712B1 (en) * 1983-06-07 1989-01-11 The Stolle Research And Development Corporation Deodorant containing bacterial antibodies
US5141742A (en) * 1986-02-07 1992-08-25 Oncogen Vaccines against melanoma
KR900701303A (ko) * 1988-07-22 1990-12-01 원본미기재 피부질환치료 및 상처 치유 촉진용 조성물 및 방법
US5571511A (en) * 1990-10-22 1996-11-05 The U.S. Government Broadly reactive opsonic antibodies that react with common staphylococcal antigens
FR2669538B1 (fr) * 1990-11-28 1995-03-03 Fondation Nale Transfusion San Utilisation d'immunoglobulines administrees localement dans le traitement des infections epitheliales.
EP0680337A4 (en) * 1993-01-12 1997-07-30 Anthony George Gristina METHODS AND COMPOSITIONS FOR DIRECT APPLICATION WITH HIGH CONCENTRATION OF ANTIBODIES, PRODUCING PASSIVE IMMUNITY.
JP3193205B2 (ja) * 1993-08-09 2001-07-30 日本臓器製薬株式会社 好酸球増多抑制剤

Also Published As

Publication number Publication date
EP0814837B2 (en) 2006-02-22
ITRM950154A0 (it) 1995-03-14
JP3939346B2 (ja) 2007-07-04
KR19980702515A (ko) 1998-07-15
JPH11501915A (ja) 1999-02-16
ATE228854T1 (de) 2002-12-15
DE69625182T2 (de) 2003-11-20
DE69625182T3 (de) 2006-08-24
CA2213500C (en) 2010-01-26
CA2213500A1 (en) 1996-09-19
PT814837E (pt) 2003-04-30
US20020192276A1 (en) 2002-12-19
DK0814837T4 (da) 2006-05-29
ES2187635T5 (es) 2006-09-01
US7217416B2 (en) 2007-05-15
DK0814837T3 (da) 2003-03-31
US6410019B1 (en) 2002-06-25
WO1996028186A1 (en) 1996-09-19
ES2187635T3 (es) 2003-06-16
ITRM950154A1 (it) 1996-09-14
EP0814837B1 (en) 2002-12-04
EP0814837A1 (en) 1998-01-07
DE69625182D1 (de) 2003-01-16

Similar Documents

Publication Publication Date Title
DE68914365D1 (de) Topische metronidazol-formulationen und deren verwendung als arzneimittel.
CA2168247A1 (en) Nitric Oxide Donor Composition and Method for Treatment of Anal Disorders
AU6286294A (en) Guanidine derivatives useful in therapy
IT1278052B1 (it) Uso delle immunoglobuline della classe g, in particolare delle immunoglobuline per uso endovenoso o per uso intramuscolare, per
MX9603596A (es) Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas.
DE69431476D1 (de) Einschlusskomplexe von taxol oder taxotere oder taxus-extrakten und cyclodextrinen, ihre herstellung und ihre verwendung
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
ITBG910042A1 (it) Preparati farmaceutici per uso topico destinati al trattamento della psoriasi e della dermatite atopica
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
DE69222318D1 (de) Hautpflegemittel
TR199700694T1 (xx) D vitamini t�revlerinin dermotolojik kullan�m�.
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
DK0700897T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
ATE245991T1 (de) Behandlung chronischer entzündungskrankheiten mit cm101/gbs-toxin
ATE120090T1 (de) Behandlung gealterter haut mit oraler 13-cis- retinsäure.
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
NO962619L (no) Psoriasisbehandling
MX9304878A (es) Uso de un azaspirano substituido en la fabricacion de un medicamento para utilizarse en el tratamiento de psoriasis.
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
BR9611033A (pt) Processos para tratar infecção por h.pylori, em um mamífero e para converter a forma coccóide de h. pylori em cultura na forma em espiral e a forma em espiral de h.pylori em cultura na forma coccóide, formulação farmaceutica e uso de um agente capaz de induzir a forma coccóide de h.pylori
DE59305285D1 (de) Transdermales therapeutisches system mit pentylentetrazol als wirkstoff
RU94023697A (ru) Средство для лечения инфекционного токсикоза у детей раннего возраста
ITGE940025A0 (it) Preparazione farmaceutica ad uso topico per la cura della psoriasi e di altre dermatosi.
UA18225A (uk) Спосіб лікуваhhя раh
GEU1998400Y (en) Ointment “Topokril” for Treating of Dermatitis

Legal Events

Date Code Title Description
0001 Granted